...
Country response
| Country | Date | Response |
|---|---|---|
| US | 17AUG2021 | If the third dose/booster is different from the initial doses (e.g., different mRNA to account for the variants), this may warrant a new concept in a drug terminology, such as RxNorm. Otherwise, no new concepts should be created. |
| Member countries without a CMAG rep |
...